How much is glyxambi?

Glyxambi (empagliflozin + linagliptin) is a prescription medication used for type‑2 diabetes. Because drug pricing varies widely by country, insurer, pharmacy, and whether you’re on a discount card or a copay program, the best estimate is a broad range:

Why the price can vary

1. Insurance coverage – The copay or coinsurance you pay depends on your plan (e.g., 20% vs. 50% coinsurance).
2. Manufacturer coupons & patient assistance – Eli Lilly (the manufacturer of Glyxambi) offers a discount card for qualifying patients, which can cut the cost by 50‑70 %.
3. Pharmacy pricing – Some community pharmacies have negotiated better wholesale prices or run “mail‑order” discounts.
4. Generic availability – At the time of writing, there is no FDA‑approved generic for Glyxambi, but if a biosimilar or generic combination becomes available, the cost will drop sharply.
5. Regional pricing regulations – Government‑price negotiations, rebate agreements, and compulsory discounts differ from country to country.

How to find the exact cost for you

1. Call your pharmacy – Ask the pharmacist to look up the current retail price and any applicable coupons.
2. Check your insurer’s portal – Many plans list out‑of‑network and in‑network copay amounts.
3. Use manufacturer discount cards – Visit Eli Lilly’s website (https://www.elililly.com/), enter your prescription details, and see if you qualify.
4. Ask your prescriber – The doctor can sometimes recommend a lower‑cost alternative or a therapeutic switch if it’s clinically appropriate.

Bottom line: In the U.S., a monthly supply of Glyxambi can run roughly $900–$1,300 without insurance, but with insurance or manufacturer discounts the out‑of‑pocket cost can be substantially lower. For the most accurate price for your situation, check with your pharmacy and insurer.